Tributary Capital Management LLC Has $25.96 Million Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Tributary Capital Management LLC decreased its position in Addus HomeCare Co. (NASDAQ:ADUS) by 0.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 207,131 shares of the company’s stock after selling 286 shares during the period. Addus HomeCare makes up 2.0% of Tributary Capital Management LLC’s investment portfolio, making the stock its 11th biggest holding. Tributary Capital Management LLC’s holdings in Addus HomeCare were worth $25,964,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Quarry LP bought a new position in shares of Addus HomeCare during the third quarter worth about $28,000. Farther Finance Advisors LLC grew its stake in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after acquiring an additional 366 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Addus HomeCare by 25.7% during the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock worth $124,000 after acquiring an additional 191 shares in the last quarter. Assetmark Inc. raised its holdings in shares of Addus HomeCare by 11.5% in the third quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after purchasing an additional 121 shares during the last quarter. Finally, Dakota Wealth Management bought a new stake in shares of Addus HomeCare in the third quarter worth $217,000. 95.35% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ADUS has been the subject of a number of recent research reports. Stephens increased their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. Finally, Macquarie reissued an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $134.22.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,750 shares of company stock worth $4,930,750 in the last ninety days. 4.60% of the stock is owned by company insiders.

Addus HomeCare Price Performance

Shares of ADUS opened at $130.62 on Friday. The firm has a market capitalization of $2.37 billion, a PE ratio of 29.89, a PEG ratio of 1.73 and a beta of 1.00. The company’s 50-day moving average is $126.10 and its 200-day moving average is $126.96. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same period last year, the business posted $1.03 earnings per share. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. Analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.